TDOC FINANCIAL STATEMENTS

Teladoc Inc — balance sheet, income statement and cash flow trends

TDOCTeladoc Inc

🇺🇸 USA · NYSE · Healthcare · Health Information Services

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue2.5 B $-1.5%

Gross Profit1.6 B $-8.3%

Operating Income-191.1 M $—

EBITDA57.3 M $+74.6%

Net Income-171.1 M $—

Peer Comparison· Health Information Services

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
TDOC	-1.5%	65.6%	2.3%	-6.8%
PME	30.3%	78.4%	78.4%	97.6%
FONET	53.5%	39.8%	49.6%	26.0%
Industry median	7.1%	63.4%	12.4%	1.5%

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
TDOC	-1.5%	65.6%	2.3%	-6.8%
OMCL	7.9%	43.5%	10.2%	1.7%
SDGR	10.6%	55.3%	-37.1%	-40.6%
CERT	6.4%	58.1%	24.1%	-3.6%
HSTM	6.6%	64.9%	22.4%	6.4%
PRVA	24.7%	9.6%	2.5%	1.0%
Industry median	7.1%	63.4%	12.4%	1.5%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity1.3 B $48%
Current Liabilities404.9 M $14%
Long-term Liabilities1.1 B $38%

Key Figures

YoY change

Total Assets2.8 B $-18.5%

Total Liabilities1.5 B $-27.1%

Total Equity1.3 B $-6.4%

Cash & ST Investments750.7 M $-37.1%

Total Debt1 B $-34.6%

Net Debt287.3 M $-27.0%

Peer Comparison· Health Information Services

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
TDOC	2.80	77.7%	5.01	47.6%
PME	6.22	1.1%	-1.16	72.8%
FONET	2.31	2.5%	-0.21	90.9%
Industry median	1.83	22.0%	-0.01	64.7%

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
TDOC	2.80	77.7%	5.01	47.6%
OMCL	1.46	16.1%	-0.71	62.7%
SDGR	2.74	34.1%	3.09	49.4%
CERT	1.88	29.5%	1.49	67.8%
HSTM	0.97	4.0%	-0.75	66.7%
PRVA	1.61	1.2%	-7.28	53.1%
Industry median	1.83	22.0%	-0.01	64.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow288 M $-4.2%

Capital Expenditures36.9 M $-60.9%

Free Cash Flow251.1 M $+21.7%

Dividends Paid——

Peer Comparison· Health Information Services

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
TDOC	11.5%	10.0%	1.5%	-168.2%
PME	56.5%	56.3%	0.2%	57.9%
FONET	45.0%	9.6%	32.1%	173.0%
Industry median	17.1%	13.0%	1.6%	165.1%

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
TDOC	11.5%	10.0%	1.5%	-168.2%
OMCL	12.7%	9.1%	3.6%	762.9%
SDGR	-56.9%	-58.2%	1.3%	140.1%
CERT	21.6%	19.7%	1.9%	-600.4%
HSTM	20.3%	19.2%	1.1%	318.2%
PRVA	6.1%	6.1%	0.1%	634.1%
Industry median	17.1%	13.0%	1.6%	165.1%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on TDOC

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.